Relay Therapeutics Inc (NASDAQ: RLAY) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Recently, Yahoo Finance discussed the stock, revealing that Relay Therapeutics to Participate in Three Upcoming Investor Conferences.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Relay Therapeutics Inc is $1.05B. A total of 0.78 million shares were traded on the day, compared to an average of 1.10M shares.

In the most recent transaction, Bergstrom Donald A sold 765 shares of RLAY for 7.70 per share on Mar 27 ’24. After the transaction, the President, R&D now owns 530,113 company shares. In a previous transaction on Mar 27 ’24, Catinazzo Thomas sold 348 shares at 7.70 per share. RLAY shares that Chief Financial Officer owns now total 341,498.

Among the insiders who sold shares, Adams Brian disposed of 348 shares on Mar 27 ’24 at a per-share price of $7.70. This resulted in the Chief Legal Officer holding 327,390 shares of RLAY after the transaction. In another insider transaction, Rahmer Peter sold 298 shares at $7.70 per share on Mar 27 ’24. Company shares held by the insider now total 514,679.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, RLAY has a high of $19.23 and a low of $5.95.

As of this writing, RLAY has an earnings estimate of -$0.7 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.63 per share and a lower estimate of -$0.81. The company reported an EPS of -$0.54 in the last quarter, which was 34.90% higher than expectations of -$0.83.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. RLAY’s latest balance sheet shows that the firm has $958.07M in Cash & Short Term Investments as of fiscal 2021. There were $22.90M in debt and $24.32M in liabilities at the time. Its Book Value Per Share was $5.90, while its Total Shareholder’s Equity was $897.81M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RLAY is Buy with a score of 4.67.

Most Popular

Related Posts